MDxHealth SA  

(Public, EBR:MDXH)   Watch this stock  
Find more results for Joseph Reyes�
4.55
+0.06 (1.34%)
Apr 24 - Close
EBR real-time data - Disclaimer
Currency in EUR
Range 4.45 - 4.59
52 week 1.92 - 5.29
Open 4.49
Vol / Avg. 120,166.00/209,032.00
Mkt cap 155.84M
P/E     -
Div/yield     -
EPS -0.36
Shares 34.25M
Beta     -
Inst. own     -
May 26, 2014
MDxHealth SA Annual Shareholder Meeting (Estimated) Add to calendar
Mar 20, 2014
MDxHealth SA at KBC Healthcare Conference
Mar 4, 2014
MDxHealth SA at Sachs Associates EUROPEAN LIFE SCIENCE CEO FORUM PARTNERING & INVESTING IN BIOTECH & PHARMA INDUSTRY Conference
Feb 24, 2014
Q4 2013 MDxHealth SA Earnings Release (Estimated)
  

Key stats and ratios

Q2 (Jun '13) 2012
Net profit margin -196.87% -195.05%
Operating margin -196.27% -193.55%
EBITD margin - -184.83%
Return on average assets -56.36% -60.21%
Return on average equity -66.26% -76.60%
Employees 70 -
CDP Score - -

Address

Tour 5 GIGA niveau +3 Av. de l'Hopital 11
LIEGE, 4000
Belgium
+32-4-3642070 (Phone)
+32-4-3642071 (Fax)

Website links

Description

MDxHealth SA (formerly known as OncoMethylome Sciences SA) is a Belgium-based biotech company dedicated to the development and commercialization of molecular diagnostic tests for early cancer detection and personalized treatment decisions. The Company develops deoxyribonucleic acid (DNA) gene methylation tests to assist physicians in detecting cancer at an early stage and in predicting a patient�s response to cancer therapy or the likelihood of cancer recurrence. The Company develops cancer diagnostic products and personalized medicine tests for different types of cancers, such as prostate cancer, colon cancer and lung cancer. The Company�s subsidiaries include OncoMethylome Sciences BV in the Netherlands, MDxHealth Inc. in the United States and MDxHealth PharmacoDx BVBA in Belgium.

Officers and directors

Jan Groen Chief Executive Officer, Executive Director
Joseph Sollee Executive Vice President - Corporate Development and Legal Affairs
Age: 48
Christopher Thibodeau Executive Vice President of Commercial Operations
Age: 42
Wim van Criekinge Ph.D. Chief Scientific Officer
Francis Ota Executive Vice President - Finance
Age: 60
Miriam Reyes Vice President - Laboratory Operations
Joseph Bigley Vice President - Clinical Affairs
Ming-Chou Lee Ph.D. Vice President - Product Development
Edward L. Erickson Chairman, Non-Executive Independent Director
Age: 67
Rudi Marien Non-Executive Director, representing Gengest BVBA
Age: 69